Synergy CHC CEO option repricing to $0.21

Synergy CHC Corp. insider activity shows an option repricing for shares held indirectly through Kenek Brands Inc., which is controlled by CEO and Chairman Ross Jack.

Rhea-AI Filing Summary

Synergy CHC Corp. insider activity shows an option repricing for shares held indirectly through Kenek Brands Inc., which is controlled by CEO and Chairman Ross Jack. A stock option for 750,000 shares of common stock with a $2.38 exercise price was deemed canceled and disposed of back to the company.

On the same date, Kenek Brands Inc. received a new stock option covering 750,000 underlying shares at a reduced exercise price of $0.21 per share. The new option keeps the original vesting schedule tied to the September 18, 2025 grant date and expires on the five-year anniversary of that date. The filing notes Jack’s indirect beneficial ownership through Kenek Brands Inc., with beneficial ownership disclaimed except for his pecuniary interest.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Ross Jack

Role CEO and Chairman

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	750,000	$0.00	$0.00
Disposition	Stock Option (right to buy)	750,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to buy) — 750,000 contracts (Indirect, By Kenek Brands Inc.)

Footnotes (3)

1. F1. One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.
2. F2. The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.
3. F3. The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Key Figures

Canceled option size: 750,000 shares Original exercise price: $2.38 per share New option size: 750,000 shares +3 more

6 metrics

Canceled option size 750,000 shares Underlying common shares in original option deemed canceled

Original exercise price $2.38 per share Exercise price of Original Option before modification

New option size 750,000 shares Underlying common shares in new option grant

New exercise price $0.21 per share Exercise price of new option after modification

Option expiration September 18, 2030 Expiration date for both original and new options

Vesting cliff 1/3 on first anniversary One-third vests on first anniversary of September 18, 2025

Key Terms

material modification, Section 16, indirect beneficial owner, pecuniary interest, +1 more

5 terms

material modification financial

"The reduction in the exercise price of the Original Option constitutes a material modification"

Section 16 regulatory

"is deemed, for purposes of Section 16, to involve a cancellation of the Original Option"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

indirect beneficial owner financial

"The reporting person is the indirect beneficial owner of the reported securities."

pecuniary interest financial

"disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein."

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Synergy CHC (SNYR) disclose about Ross Jack’s stock options?

Synergy CHC disclosed that an indirect entity controlled by CEO Ross Jack canceled a stock option for 750,000 shares at a $2.38 exercise price and received a new option over the same 750,000 shares at a reduced $0.21 exercise price, with vesting terms unchanged.

How many Synergy CHC (SNYR) shares are covered by the repriced option?

The transaction involves stock options linked to 750,000 underlying shares of Synergy CHC common stock. One 750,000-share option was deemed canceled, and a new 750,000-share option was granted, keeping the same share count while changing the exercise price and preserving the vesting schedule.

What are the old and new exercise prices in the Synergy CHC (SNYR) Form 4?

The original option carried a $2.38 per share exercise price, which was treated as canceled. The new option for the same 750,000 underlying shares has a significantly lower $0.21 per share exercise price, while maintaining the same vesting schedule and a five-year term from the original grant date.

Who holds the Synergy CHC (SNYR) options reported in this filing?

The options are held directly by Kenek Brands Inc., which is controlled by CEO and Chairman Ross Jack. He is reported as the indirect beneficial owner, but the filing states he disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in Kenek Brands Inc.

How does the vesting schedule work for the new Synergy CHC (SNYR) option grant?

The new option vests on the same schedule as the original grant tied to September 18, 2025. One-third of the option vests on the first anniversary of that date, and the remaining two-thirds vest in equal monthly installments over 24 months, contingent on continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ross Jack

(Last) (First) (Middle)

C/O SYNERGY CHC CORP.

770 ROOSEVELT TRAIL STE 8 #1016

(Street)

N. WINDHAM MAINE 04062

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$0.21	06/29/2026		A		750,000		(1)	09/18/2030	Common Stock, par value $0.00001 per share	750,000	(2)	750,000	I(3)	By Kenek Brands Inc.
Stock Option (right to buy)	$2.38	06/29/2026		D			750,000	(1)	09/18/2030	Common Stock, par value $0.00001 per share	750,000	(2)	0	I(3)	By Kenek Brands Inc.

Explanation of Responses:

1. One-third (1/3) of this option grant (the "Original Option") vests on the first anniversary of September 18, 2025 (the "Original Grant Date"), and the remaining two-thirds (2/3) vest in equal monthly installments over the twenty-four (24) months thereafter, in each case subject to the reporting person's continued service with the Company.

2. The reduction in the exercise price of the Original Option constitutes a material modification and is deemed, for purposes of Section 16, to involve a cancellation of the Original Option and the grant of a new option in its place. The new option vests on the same schedule as the Original Option, as if it had been granted on the Original Grant Date, and expires on the five-year anniversary of the Original Grant Date.

3. The reported securities are owned directly by Kenek Brands Inc., which is controlled by the reporting person. The reporting person is the indirect beneficial owner of the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

	/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)